Development and validation of a new risk assessment model for immunomodulatory drug-associated venous thrombosis among Chinese patients with multiple myeloma.
Thromb J
; 21(1): 105, 2023 Oct 04.
Article
in En
| MEDLINE
| ID: mdl-37794471
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Etiology_studies
/
Guideline
/
Prognostic_studies
/
Risk_factors_studies
Language:
En
Journal:
Thromb J
Year:
2023
Document type:
Article
Affiliation country:
China
Country of publication:
Reino Unido